|Articles|June 1, 2008

Pharmaceutical Executive

  • Pharmaceutical Executive-06-01-2008
  • Volume 0
  • Issue 0

Rich Tillyer, Merck

S

Rich Tillyer

Senior Vice President, Worldwide Preclinical Development, Merck

CAREER JOLT: Moved to Manufacturing

YOU DIDN'T KNOW: "I can't swim"

As the head of preclinical development, Rich Tillyer has helped lead Merck's radical redesign of its storied R&D establishment. In this overturning of tradition, his youth—and abundant British charm—have played a critical role. "I think younger leaders are much better at connecting with employees, so that folks can understand the macro decisions we make," he says. "But we also work to keep folks motivated and focused on their mission."

Rich Tillyer

Like other young stars, Tillyer credits his passion in the lab for his fast rise. But in fact, his capacity to embrace change may have been the decisive factor. His biggest break came disguised as his biggest disruption. Six years in and still a self-described "immature chemist," he was yanked out of the lab and installed as support for the president of the manufacturing division. "At first I was reluctant. Here were these big executives and I was running meetings for them," he recalls. But the two-year stint provided a crash course "in what manufacturing's all about, including the marketing and regulatory aspects."

Once back in the lab, he began integrating—gasp!—cost-effectiveness.

Articles in this issue

almost 18 years ago

Mary Szela, Abbott

almost 18 years ago

Mightier Than the Sword

almost 18 years ago

Eric Floyd, Cephalon

almost 18 years ago

Nancy Phelan, Wyeth

almost 18 years ago

Tightening the Chain

almost 18 years ago

Kurt Graves, Vertex

almost 18 years ago

Wendy Niebler, Shire

almost 18 years ago

Perfectly Imperfect

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.